entertainment -WSS

entertainment

author：hotspot 2025-10-03 00:38:42 - browse：73

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Bernie brings in new pharma CEOs to talk drug prices

explore

WSS

UnitedHealth financials solid despite Change Healthcare cyberattack

More tobacco lobbyists active in statehouses

The CDC's new social media misinformation war

Getting Alzheimer's drug Leqembi to patients can be a challenge

Medical bills so high, Medicare adding extra digits to claim forms

Johnson & Johnson sued for allegedly overpaying for workers' drugs

entertainment

entertainment

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Why Novartis is going to walk from its acquisition of MorphoSys

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A protest over insulin prices is seen as a fight for life

Moonlake's readout produced a cash windfall. Risks remain

H5N1 bird flu virus started spreading in cows in Texas in December

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Health care needs a new profession: neuroimaging counseling

How to save PrEP access — and even expand it

The Biogen Aduhelm mess could happen again

entertainment

Key Senate committee drafts bipartisan bill to stem drug shortages

A protest over insulin prices is seen as a fight for life

Orangutan used medicinal plant to treat wound, first time ever seen

Bird flu outbreak in cows is latest avian flu curveball

Exact Sciences stock tumbles despite strong cancer detection sales

AI gets buy

explore

explore

explore

Wikipedia